AnaptysBio Inc buy UBS Group AG
Start price
17.03.26
/
50%
€58.00
Target price
17.03.27
€78.28
Performance (%)
-10.03%
Price
17.08.26
€51.30
Summary
This prediction is currently active. The prediction for AnaptysBio Inc disappoints with a performance of -10.03%. This prediction currently runs until 17.03.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 3.018% | 3.018% |
| iShares Core DAX® | -0.046% | 5.960% |
| iShares Nasdaq 100 | 0.922% | 3.693% |
| iShares Nikkei 225® | 3.014% | 6.638% |
| iShares S&P 500 | -0.359% | 2.747% |
Comments by UBS_Group_AG for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (ANAB) had its price target raised by UBS Group AG from $70.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat